• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. American Journal of Drug Discovery and Development
  2. Vol 1 (1), 2011
  3. 49-57
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

American Journal of Drug Discovery and Development

Year: 2011 | Volume: 1 | Issue: 1 | Page No.: 49-57
DOI: 10.3923/ajdd.2011.49.57

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 80

Authors


M. Santhana  Ramasamy

M. Santhana Ramasamy

LiveDNA: 91.344

P. Arumugam


S. Manikandan


A. Murugan


Keywords


  • cono peptides
  • conotoxins
  • herapeutic targets
  • Venome
Review Article

Molecular and Combinatorial Array of Therapeutic Targets from Conotoxins

M. Santhana Ramasamy M. Santhana  Ramasamy's LiveDNA, P. Arumugam, S. Manikandan and A. Murugan
Marine gastropod molluscs known as cone snails produce a complex array of over 50,000 peptides evolved for defense and prey capture. These venom peptides of predatory snails represent a rich combinatorial like library of evolutionary selected, neuro pharmacologically active. A major portion of the venom components are small, disulphide rich peptides that potently and specifically target and modulate components of the neuromuscular system, particularly ligand gated, voltage gated ion channels and transporters, making them a valuable source of new ligands for studying the role of these targets play in normal and disease physiology. Conotoxins are genetically encoded a propeptides which following expression and cleaved by specialized endoprotease to produce the mature venom peptide. A vast number of conuspeptides reduce neuropathic pain in animal models. Though several peptide drugs are in preclinical and clinical development for the treatment of severe pain often associated with diseases such as cancer, less than 1% of cono peptides are pharmacologically explored. This review focuses on the fundamental aspects and families of conotoxins in addition to some of the novel conopeptides acting at different types of Voltage gated and ligand gated ion channels which may lead to molecular and therapeutic targets.
PDF Fulltext XML References Citation

How to cite this article

M. Santhana Ramasamy, P. Arumugam, S. Manikandan and A. Murugan, 2011. Molecular and Combinatorial Array of Therapeutic Targets from Conotoxins. American Journal of Drug Discovery and Development, 1: 49-57.

DOI: 10.3923/ajdd.2011.49.57

URL: https://scialert.net/abstract/?doi=ajdd.2011.49.57

Related Articles

Selective Constraint: A Hallmark of Genes Successfully Targeted for Pharmaceutical Development
Pharmacognostic and Biochemical Properties of Certain Biomarkers in Snake Venom

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved